Mercia Fund Management provides $400,000 in follow-on funding to Leicester University spinout MIP Diagnostics as it completes set milestones and sets up its sales pipeline.
MIP Diagnostics, a Leicester University spinout creation plastic antibodies, has raised £300,000 ($400,000) in follow-on funding from Mercia Fund Management.
Mercia Fund Management is wholly owned by technology investor Mercia Technology. While Mercia Technology focuses on later stage investments, Mercia Fund Management focuses on early-stage investments.
MIP, established in 2015, provides an alternative to traditional antibodies that are created from polymers and used in drug-discovery and point-of-care diagnostics. These traditional antibodies can be unreliable due to their fragility and how…
